OKLAHOMA CITY, OK--(Marketwire - Mar 1, 2013) - On February 27, 2013, a class action lawsuit was filed in the …
Wall Street ratings agencies set the tone for today's stock market. Affymax (AFFY): Citing an investigation of serious hypersensitivity reactions, some deadly, centering on the company's Omontys treatment, MLV & Co slashes the micro …
It has been a tough start to the week for shareholders in Affymax (AFFY), with the company’s stock selling off 85% at the open Monday morning. The the selloff highlights the inherent risks associated with investing in biotech companies, …
--(BUSINESS WIRE)--Affymax, Inc. (AFFY), a biopharmaceutical company ... based on 37,490,095 shares of common stock outstanding as of April 30, 2014 and the remaining cash of approximately $4 million as of May 2014. Plan of …
Affymax /quotes/zigman/104161 /quotes/nls/affy AFFY plunged by more than 57% to $1.25 ... But Raymond didn’t cut his neutral rating on the stock — which he dubbed Affymax shares in February. There are slight possibilities for the …
Aug 28 (Reuters) - Affymax Inc AFFY.O said it would stop developing its anemia drug ... Takeda shares closed down nearly 2 percent at 5,640 yen on the Tokyo Stock Exchange. (Reporting by Esha Dey in Bangalore; Editing by …
StockCall has issued technical analysis and charting reports on AFFY, AMGN, PDLI, QCOR, and BCRX. Download these free reports now at www.stockcall.com/todaysopinions Affymax Inc.’s stock finished 7.50% lower at $1.11 with a total …
If you think outlet shopping for designer clothing is a great idea, here's something you can really sink your teeth into: food outlets. At the factory store ... Prices vary widely, and depend on the quantity in stock, the quality and how badly the …
Affymax Inc. (AFFY) announced Monday morning that the primary endpoint ... Monday morning and is now down 14.71 at $8.30 on the highest volume of the year. The stock has dropped to a new low for the year.
Alcatel-Lucent (ALU): The telecom stock gets taken to Underweight from Neutral at HSBC Securities. Affymax (AFFY): Robert W. Baird is one of many firms reducing its recommendation today, taking it to Neutral from Outperform and …